Vertex Misses Q1 Estimates on Trikafta Sales, But Hints at Growth via Journavx & Gene Therapy
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameVertex Pharmaceuticals Incorporated
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









